Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Clinical trial NCT04095793 · TERMINATED

Trial details

NCT number: NCT04095793
Sponsor: Theravance Biopharma
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Symptomatic Neurogenic Orthostatic Hypotension

Start date: 2019-09-19
Primary completion: 2021-11-12
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.